Browsing "School of Medicine / Graduate School of Medicine" by Publication Year :
Showing results 181 to 200 of 513
| Pub Year | | Title | Author(s) |
| 2017 | | Method for preparing biocompatible porcine cartilage-derived extracellular matrix membrane having adjustable in vivo degradation rate and mechanical property and composition to prevent the adhesion between tissues and/or organs | 김영직, 민병현 |
| 2017 | | PCL patch scaffold for tissue regeneration and preparing method thereof | 정연훈 |
| 2017 | | Biomarker composition for diagnosing still''s diseases, diagnosing kit, and diagnosing method | 김현아, 손성향 |
| 2017 | | Method and Apparatus for jaundice diagnosis based on an image, Assisting Apparatus for jaundice diagnosis based on an image | 김진홍 |
| 2017 | | Biomarker composition for diagnosing cancer with mitochondrial dysfunction comprising NUPR1 and method for diagnosing cancer using the same marker | 우현구, 윤계순, 이영경 |
| 2017 | | Screening Method of therapeutic agents for cancer with mitochondrial dysfunction by regulation of Claudin-1 expression | 윤계순, 이영경 |
| 2017 | | Composition for Preventing or Treating Osteoarthritis Comprising 3'-Siallylactose or Derivatives Thereof | 강이중, 양시영 |
| 2017 | | Composition for Preventing or Treating Osteoarthritis Comprising 6'-Sialyllactose or Salts Thereof | 강이중, 양시영 |
| 2017 | | Pharmaceutical composition for preventing or treating miRNA-34a related diseases comprising inducer or activator of TIS21 and screening method thereof | 유민숙, 임인경 |
| 2017 | | Method for Diagnosing Recurrent Cancer Using GOLGB1 or SF3B3 and Composition for Treating Recurrent Cancer Containing Inhibitors of GOLGB1 or SF3B3 | 우현구, 최지혜 |
| 2017 | | Method for Prediction of Susceptibility to Sorafenib Using SULF2 Gene and Composition for Treating Cancer Containing SULF2 Inhibitor | 우현구, 윤사라, 이은주 |
| 2017 | | Biomarker composition for predicting prognosis of intrahepatic cholangiocarcinoma | 우현구 |
| 2017 | | Functional gloves for grasping ultrasonic probe | 홍지만 |
| 2017 | | Biomarker composition for predicting prognosis of intrahepatic cholangiocarcinoma comprising 794 gene set | 우현구 |
| 2017 | | Method of Normalization for Combination of Clinical Data from Different Electronic Healthcare Databases and System thereof | 박래웅, 윤덕용 |
| 2017 | | Pharmaceutical composition for treating CNS injury-related diseases comprising CCL2 or CCL2 agonist | 권민정, 김병곤 |
| 2016 | | Composition for preventing or treating autoimmune diseases or transplant rejection comprising human fetal cartilage-derived cells | 민병현 |
| 2016 | | PHARMACEUTICAL COMPOSITION COMPRISING CYSTEINYL LEUKOTRIENE RECEPTOR ANTAGONIST AND GINKGO BILOBA EXTRACT FOR TREATING OR PREVENTING SENSORINEURAL HEARING LOSS | 김연주, 박상면, 박정섭, 정연훈 |
| 2016 | | Anti-cancer supplement agent comprising flunarizine for glioma | 김인영, 최경숙 |
| 2016 | | MANUFACTURING METHOD OF NANOFIBER STRUCTURE COMPRIGING FUCOIDAN WITH ENHANCED CELL ADHESION AND NANOFIBER STRUCTURE COMPRIGING FUCOIDAN MADE BY THE SAME | 곽종영, 김정민 |
